Tag: ESMO
July 26, 2017
Oncolytics Biotech to Present REOLYSIN Safety Data
Oncolytics Biotech announced two abstracts describing both pooled safety and tolerability data and the mechanism of REOLYSIN will be presented... December 19, 2016
Loxo Oncology Outlines Plans for Accelerated Path to US FDA Approval for Larotrectinib
Loxo Oncology today announced a comprehensive program update for larotrectinib (LOXO-101), a selective inhibitor of tropomyosin receptor kinase (TRK), and... December 9, 2016
Novartis LEE011 (ribociclib) Plus Letrozole Analyses Show Superior PFS in First-Line HR+/HER2- Advanced Breast Cancer
Novartis announced today additional analyses from the Phase III MONALEESA-2 study that show LEE011 (ribociclib) plus letrozole significantly prolonged progression-free...
November 13, 2016
5 Top NASDAQ Biotech Stocks: PTC Therapeutics Gains 88 Percent
Last week's top gainer was PTC Therapeutics followed by Cogentix Medical, Concordia International, Galectin Therapeutics and XOMA. November 7, 2016
Dynavax Reports Third Quarter 2016 Financial Results and Company Update
Dynavax Technologies Corporation (NASDAQ: DVAX) today reported financial results for the third quarter and nine months ended September 30, 2016.
November 6, 2016
5 Top NASDAQ Biotech Stocks: AveXis, Inc. Leads
Last week's top gainer was AveXis, Inc. followed by Heska Corp., Corcept Therapeutics, Atara Biotherapeutics and Seattle Genetics Inc.
October 30, 2016